FinscoFinsco

ConMed (US.CNMD)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CNMD · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion88.5%→
ROE3.5%↑
Cash Conversion137.0%↓
D/E Ratio0.80↑
Gross Margin57.7%→
US.CNMD (ConMed) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion    88.5%    →
ROE                3.5%    ↑
Cash Conversion  137.0%    ↓
D/E Ratio          0.80    ↑
Gross Margin      57.7%    →
Key Metrics
US.CNMD (ConMed) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 88.5% →
ROE 3.5% ↑
Cash Conversion 137.0% ↓
D/E Ratio 0.80 ↑
Gross Margin 57.7% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies